Page last updated: 2024-11-06

prednisolone and Myxedema

prednisolone has been researched along with Myxedema in 21 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research Excerpts

ExcerptRelevanceReference
"A 39-year-old woman with primary myxedema, who had the potent activities of thyrotropin-binding inhibitory immunoglobulins (TBII) and thyroid-stimulation blocking antibodies (TSBAb), developed aortitis syndrome about 6 months after the initiation of L-thyroxine (L-T4) supplementation."7.68Disappearance of thyroid-stimulation blocking antibody by glucocorticoid therapy in a patient with primary myxedema who developed aortitis syndrome during L-thyroxine supplementation. ( Kouchi, T; Mashiba, H; Mitani, Y; Shigemasa, C; Taniguchi, S, 1990)
"Scleromyxedema is a rare mucinous disease without thyroid dysfunction, associated with a monoclonal gammopathy."5.31[Initial scleromyxedema. Successful treatment with melphalan]. ( Meurer, M; Schubert, K; Stein, A, 2002)
"A 39-year-old woman with primary myxedema, who had the potent activities of thyrotropin-binding inhibitory immunoglobulins (TBII) and thyroid-stimulation blocking antibodies (TSBAb), developed aortitis syndrome about 6 months after the initiation of L-thyroxine (L-T4) supplementation."3.68Disappearance of thyroid-stimulation blocking antibody by glucocorticoid therapy in a patient with primary myxedema who developed aortitis syndrome during L-thyroxine supplementation. ( Kouchi, T; Mashiba, H; Mitani, Y; Shigemasa, C; Taniguchi, S, 1990)
" The ratio of 3-methylhistidine:creatinine excretion, a measure of the fractional catabolic rate of myofibrillar protein was increased in severe injury, thyrotoxicosis, neoplastic disease, prednisolone administration, and sometimes Duchenne muscular dystrophy."3.66Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown. ( Bacon, S; Carter, A; Elia, M; Smith, R; Winearls, CG, 1981)
"A 66-year-old man presented with Graves' disease and widespread localized myxedema."2.39Localized myxedema, associated with increased serum hyaluronic acid, and response to steroid pulse therapy. ( Goto, Y; Kohda, H; Mizuta, T; Ohtsuka, Y; Ozaki, I; Sakai, T; Setoguchi, Y; Yamamoto, K, 1995)
"Scleromyxedema is a rare mucinous disease without thyroid dysfunction, associated with a monoclonal gammopathy."1.31[Initial scleromyxedema. Successful treatment with melphalan]. ( Meurer, M; Schubert, K; Stein, A, 2002)
"Scleromyxedema is the consequence of a dermal infiltration by mucine, commonly associated with a monoclonal gammapathy of unknown significance."1.31[Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus]. ( Achin, R; Bacin, F; Beyvin, AJ; D'Incan, M; Demeocq, F; Franck, F; Kanold, J; Souteyrand, P, 2001)
"Scleromyxedema is an uncommon disease of unclear etiology."1.31[Extracorporeal photopheresis--treatment option in scleromyxedema?]. ( Bock, M; Durani, BK; Näher, H, 2001)

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19909 (42.86)18.7374
1990's5 (23.81)18.2507
2000's4 (19.05)29.6817
2010's2 (9.52)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Perepelova, MA1
Zaitseva, EL1
Bessmertnaya, EG1
Grusha, YO1
Sviridenko, NY1
Galstyan, GR1
Shirai, K1
Ito, T1
Mitsuhashi, Y1
Tsuboi, R1
Sendhil Kumaran, M1
Dutta, P1
Sakia, U1
Dogra, S1
Schubert, K1
Stein, A1
Meurer, M1
Lin, YC1
Wang, HC1
Shen, JL1
Elia, M1
Carter, A1
Bacon, S1
Winearls, CG1
Smith, R1
Ohtsuka, Y1
Yamamoto, K1
Goto, Y1
Mizuta, T1
Ozaki, I1
Setoguchi, Y1
Kohda, H1
Sakai, T1
Kitamura, Y1
Yoshida, T1
Tsusaka, N1
Akizuki, M1
Handa, M1
Ikeda, Y1
Momotani, M1
Ito, K1
Tsushima, T1
D'Incan, M1
Franck, F1
Kanold, J1
Bacin, F1
Achin, R1
Beyvin, AJ1
Demeocq, F1
Souteyrand, P1
Durani, BK1
Bock, M1
Näher, H1
Shigemasa, C1
Kouchi, T1
Taniguchi, S1
Mitani, Y1
Mashiba, H1
Keong, CH1
Asaka, Y1
Fukuro, S1
Miyamoto, C1
Katsumata, M1
Iino, Y1
Komiya, T1
Göring, HD1
Ziemer, A1
Benoit, FL1
Greenspan, FS1
Pickardt, CR1
Boergen, KP1
Heinze, HG1
Murase, T1
Mukoyama, A1
Osawa, N1
Nagataki, S1
Yamaji, T1
Roberts, CI1
Zeltner, G1
Fekete, T1
Panyi, M1
Hausmann, W1
Potter, B1

Reviews

3 reviews available for prednisolone and Myxedema

ArticleYear
Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
    The Journal of dermatology, 2006, Volume: 33, Issue:3

    Topics: Adult; Glucocorticoids; Humans; Male; Myxedema; Prednisolone; Skin Diseases

2006
Localized myxedema, associated with increased serum hyaluronic acid, and response to steroid pulse therapy.
    Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:5

    Topics: Administration, Oral; Aged; Drug Therapy, Combination; Graves Disease; Humans; Hyaluronic Acid; Inje

1995
[Emergency drug therapy of thyroid disease].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Nov-10, Volume: 84, Issue:11

    Topics: Agranulocytosis; Antithyroid Agents; Emergencies; Humans; Hydrocortisone; Iodine; Myxedema; Predniso

1995

Other Studies

18 other studies available for prednisolone and Myxedema

ArticleYear
[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].
    Problemy endokrinologii, 2023, 08-30, Volume: 69, Issue:4

    Topics: Graves Disease; Graves Ophthalmopathy; Humans; Myxedema; Patients; Prednisolone

2023
Dramatic effect of low-dose oral steroid on elephantiasic pretibial myxedema.
    The Journal of dermatology, 2014, Volume: 41, Issue:10

    Topics: Adult; Elephantiasis; Glucocorticoids; Humans; Leg Dermatoses; Male; Myxedema; Prednisolone

2014
Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
    International journal of dermatology, 2015, Volume: 54, Issue:8

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Clobetasol; Drug Therapy, Combination;

2015
[Initial scleromyxedema. Successful treatment with melphalan].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2002, Volume: 53, Issue:7

    Topics: Aged; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Facial Dermatoses; Female; Humans;

2002
Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
    British medical journal (Clinical research ed.), 1981, Jan-31, Volume: 282, Issue:6261

    Topics: Adolescent; Adult; Aged; Child; Creatinine; Diabetes Mellitus; Diet; Female; Hip Joint; Histidine; H

1981
[Case of EMO syndrome treated with plasma exchange].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Feb-10, Volume: 83, Issue:2

    Topics: Bone Diseases; Exophthalmos; Humans; Male; Middle Aged; Myxedema; Osteoarthropathy, Primary Hypertro

1994
[Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    Annales de dermatologie et de venereologie, 2001, Volume: 128, Issue:1

    Topics: Combined Modality Therapy; Female; Glucocorticoids; Humans; Middle Aged; Myxedema; Photopheresis; Pr

2001
[Extracorporeal photopheresis--treatment option in scleromyxedema?].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:10 Pt 2

    Topics: Administration, Oral; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female;

2001
Disappearance of thyroid-stimulation blocking antibody by glucocorticoid therapy in a patient with primary myxedema who developed aortitis syndrome during L-thyroxine supplementation.
    Journal of endocrinological investigation, 1990, Volume: 13, Issue:5

    Topics: Adult; Aortic Arch Syndromes; Autoantibodies; Female; Humans; Immunoglobulins, Thyroid-Stimulating;

1990
Successful treatment of scleromyxedema with plasmapheresis and immunosuppression.
    Journal of the American Academy of Dermatology, 1990, Volume: 22, Issue:5 Pt 1

    Topics: Cyclophosphamide; Fibroblasts; Humans; Immunosuppression Therapy; Male; Middle Aged; Myxedema; Plasm

1990
[Immunopathogenetic, endocrinologic and therapeutic problems of EMO syndrome. Observations based on a case report].
    Dermatologische Monatschrift, 1989, Volume: 175, Issue:8

    Topics: Autoantibodies; Azathioprine; Female; Graves Disease; Humans; Leg Dermatoses; Microsomes; Middle Age

1989
Corticoid therapy for pretibial myxedema. Observations on the long-acting thyroid stimulator.
    Annals of internal medicine, 1967, Volume: 66, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; Female; Fluocinolone Acetonide; Humans; Hyperthyroidism; Long-Ac

1967
[Endocrine ophthalmopathy].
    Der Internist, 1974, Volume: 15, Issue:10

    Topics: Endocrine System Diseases; Eye Diseases; Eye Manifestations; Graves Disease; Humans; Hyperthyroidism

1974
A survival case of myxedema coma of pituitary origin.
    Endocrinologia japonica, 1973, Volume: 20, Issue:3

    Topics: Administration, Oral; Adult; Coma; Female; Glucose; Humans; Hypopituitarism; Injections, Intravenous

1973
Mixed monoclonal-polyclonal gammopathy.
    Guy's Hospital reports, 1969, Volume: 118, Issue:4

    Topics: Adult; Antibodies, Antinuclear; Autoimmune Diseases; Blood Protein Electrophoresis; Female; Hepatiti

1969
[Successful treatment of myxedematous coma].
    Orvosi hetilap, 1972, Jan-30, Volume: 113, Issue:5

    Topics: Aged; Coma; Female; Humans; Myxedema; Prednisolone; Respiration, Artificial; Thyronines

1972
Myxoedema crisis.
    Hormones, 1970, Volume: 1, Issue:2

    Topics: Adrenal Glands; Aged; Blood Pressure; Body Temperature; Coma; Female; Humans; Hydrocortisone; Male;

1970
Autosensitivity erythema?
    Archives of dermatology, 1968, Volume: 97, Issue:1

    Topics: Adenocarcinoma, Papillary; Autoimmune Diseases; Blood Cell Count; Blood Platelets; Erythema; Female;

1968